STOCK TITAN

Elevance Health Inc - ELV STOCK NEWS

Welcome to our dedicated news page for Elevance Health (Ticker: ELV), a resource for investors and traders seeking the latest updates and insights on Elevance Health.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Elevance Health's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Elevance Health's position in the market.

Rhea-AI Summary
Elevance Health (ELEV) Announces No-Cost Access to Digital Health Tools Funded by Affordable Connectivity Program
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.62%
Tags
none
-
Rhea-AI Summary
Paragon Healthcare, Inc. (NYSE: ELV) has been sold to Elevance Health, an affiliate of Peak Rock Capital, doubling revenues and increasing the number of infusion centers by 400% during Peak Rock's ownership.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.99%
Tags
none
-
Rhea-AI Summary
Elevance Health (NYSE: ELV) announced the acquisition of Paragon Healthcare, Inc., specializing in infusible and injectable therapies. Paragon Healthcare provides infusion services through ambulatory infusion centers, home infusion pharmacies, and other specialty pharmacy services. The acquisition aims to provide affordable, convenient access to specialty medications and services for patients with chronic and complex illnesses. Paragon Healthcare serves over 35,000 patients across 8 states and will operate as part of CarelonRx, Elevance Health's health services division. The acquisition is expected to close in the first half of 2024 and is not expected to have a material impact on adjusted earnings per share in 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.91%
Tags
Rhea-AI Summary
AM Best Affirms Excellent Ratings for Elevance Health, Inc. (NYSE: ELV) and Subsidiaries
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.41%
Tags
none
-
Rhea-AI Summary
Elevance Health, Inc. (NYSE: ELV) received the new Health Equity Accreditation Plus for 21 of its affiliated Medicaid plans from the National Committee for Quality Assurance (NCQA), validating its leadership in developing solutions to ensure access to high quality, equitable healthcare. The company's approach to health equity prioritizes the needs of individuals who have been economically and socially marginalized, serving more than 10 million individuals nationwide.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.68%
Tags
none
-
Rhea-AI Summary
AM Best assigns indicative Long-Term Issue Credit Ratings to Elevance Health, Inc. with a stable outlook, noting the company's ability to manage financial leverage and maintain strong earnings coverage.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.6%
Tags
none
Rhea-AI Summary
Elevance Health is investing $1.42 million to support the NICHE - Medical project, aimed at making IDD training mainstream in medical schools. Currently, 73% of medical students graduate with no IDD training. Elevance Health has already awarded funds to seven medical schools in 2023, and is accepting proposals for future funding.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.76%
Tags
none
-
Rhea-AI Summary
Elevance Health, Inc. reported strong financial performance in Q3 2023 with a GAAP net income of $5.45 per share and adjusted net income of $8.99 per share. Operating gain grew 12.6% YoY to $2.5 billion. Operating cash flow was $2.6 billion.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.78%
Tags
-
Rhea-AI Summary
Elevance Health (NYSE: ELV) will release Q3 2023 financial results on October 18, 2023. Conference call at 8:30 a.m. EDT. Webcast available at www.elevancehealth.com.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.35%
Tags
Rhea-AI Summary
Elevance Health's affiliated health plans will offer simplified and flexible Medicare Advantage plans with customizable supplemental benefits to respond to consumer preferences. Expansion into 91 new counties will provide more options for convenient access to affordable healthcare. 93% of Medicare-eligible individuals in the states and territories served will have access to the plans. Plans will emphasize affordability with 9 out of 10 plans at $0 premium and improved prescription drug coverage. Dental care, hearing aids, and easier access to care will also be prioritized. Plans will offer Essential Extras, allowing members to tailor their plan to their specific needs. Plans will have a personalized customer service model and clinical interventions to improve outcomes. Wellpoint, formerly Amerigroup, will be the new name for affiliated health plans in select states. Medicare Advantage plans are offered under various brands including Wellpoint, HealthSun, Simply Healthcare, Freedom Health, Optimum HealthCare, and MMM in Puerto Rico.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Elevance Health Inc

NYSE:ELV

ELV Rankings

ELV Stock Data

115.72B
232.05M
0.21%
92.17%
0.9%
Direct Health and Medical Insurance Carriers
Finance and Insurance
Link
US
Indianapolis

About ELV

Elevance Health, Inc. is an American health insurance provider. Prior to June 2022, Elevance Health was named Anthem, Inc.